Internal Medicine, Rheumatology · Noblesville, IN
NPI
1083689939
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
5
Medicare group memberships
Hospitals
4
Hospital affiliations
17840 Cumberland Rd
Noblesville, IN, 46060
Phone (317) 574-1254
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
1,932 services
Medicare patients, 2024
205
Average age 71
Drug cost, 2024
$5.0M
3,449 prescriptions
Company payments, 2025
$92.69
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gregory M Bell was code J1010 (injection, methylprednisolone acetate, 1 mg), 1,320 times for 17 patients. In total Gregory M Bell billed 1,932 services in 14 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,320 | 17 | $0.10 | $135 |
| 99214 Office E&M - Established | Office | 351 | 194 | $77.76 | $27K |
| 99204 Office E&M - New | Office | 30 | 30 | $107.58 | $3,227 |
| 96372 Injection Administration | Office | 22 | 18 | $9.59 | $211 |
By year: 2022 $66K for 2,323 services; 2023 $61K for 1,990 services; 2024 $35K for 1,932 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gregory M Bell prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 376 prescriptions and refills. In total Gregory M Bell wrote 3,449 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 376 | 869 | 101 | $6,768 |
| Sulfasalazine Dr Sulfasalazine | 343 | 863 | 116 | $15K |
| Hydroxychloroquine Sulfate Generic | 259 | 695 | 84 | $11K |
| Colchicine Generic | 256 | 550 | 83 | $17K |
| Celecoxib Generic | 217 | 553 | 76 | $10K |
| Methylprednisolone Generic | 205 | 205 | 153 | $1,203 |
| Enbrel Sureclick Etanercept | 187 | 187 | 17 | $1.4M |
| Leflunomide Generic | 173 | 387 | 50 | $9,183 |
| Prednisone Generic | 145 | 232 | 52 | $1,165 |
| Humira(Cf) Pen Adalimumab | 92 | 94 | 14 | $862K |
| Gabapentin Generic | 85 | 198 | 29 | $1,361 |
| Allopurinol Generic | 82 | 228 | 21 | $717 |
| Sulfasalazine Generic | 78 | 206 | 34 | $1,674 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 63 | 63 | Under 11 | $496K |
| Mycophenolate Mofetil Generic | 61 | 152 | 16 | $7,357 |
Brand drugs: - claims; generic drugs: 2,319 claims; opioid claims: 40.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gregory M Bell $92.69 ($92.69 in general payments such as food, travel and fees) from 5 companies. The largest payer was Alexion Pharmaceuticals, Inc. with $25.69.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.